InMed Pharmaceuticals, Inc. (NASDAQ: INM)

InMed Pharmaceuticals, Inc. (NASDAQ: INM) is a clinical stage pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates targeting the CB1/CB2 receptors.

Keynote speaker: Eric Adams, CEO